These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8578811)

  • 1. An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system.
    Perrin P; Madhusudana S; Gontier-Jallet C; Petres S; Tordo N; Merten OW
    Vaccine; 1995 Sep; 13(13):1244-50. PubMed ID: 8578811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of various serum and animal protein free media for the production of a veterinary rabies vaccine in BHK-21 cells.
    Kallel H; Jouini A; Majoul S; Rourou S
    J Biotechnol; 2002 May; 95(3):195-204. PubMed ID: 12007860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the new serum-free medium (MDSS2) for the production of different biologicals: use of various cell lines.
    Merten OW; Kierulff JV; Castignolles N; Perrin P
    Cytotechnology; 1994; 14(1):47-59. PubMed ID: 7765112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media.
    Rourou S; Ben Zakkour M; Kallel H
    Vaccine; 2019 Nov; 37(47):6987-6995. PubMed ID: 31201054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An animal component free medium that promotes the growth of various animal cell lines for the production of viral vaccines.
    Rourou S; Ben Ayed Y; Trabelsi K; Majoul S; Kallel H
    Vaccine; 2014 May; 32(24):2767-9. PubMed ID: 24583007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vero-cell rabies vaccine produced using serum-free medium.
    Frazatti-Gallina NM; Mourão-Fuches RM; Paoli RL; Silva ML; Miyaki C; Valentini EJ; Raw I; Higashi HG
    Vaccine; 2004 Dec; 23(4):511-7. PubMed ID: 15530700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel process for the production of a veterinary rabies vaccine in BHK-21 cells grown on microcarriers in a 20-l bioreactor.
    Kallel H; Rourou S; Majoul S; Loukil H
    Appl Microbiol Biotechnol; 2003 Jun; 61(5-6):441-6. PubMed ID: 12764557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
    Rourou S; van der Ark A; van der Velden T; Kallel H
    Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivated rabies vaccine produced from the Flury LEP strain of virus grown in BHK-21 suspension cells.
    Chapman WG; Ramshaw IA; Crick J
    Appl Microbiol; 1973 Dec; 26(6):858-62. PubMed ID: 4588193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective antibody response of Balb/c mice to Bali rabies virus isolate propagated in BHK-21 cells.
    Astawa INM; Agustini NLP; Masa Tenaya IW; Aryawiguna IPGW
    J Vet Med Sci; 2018 Nov; 80(10):1596-1603. PubMed ID: 30210066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of rabies vaccine by an industrial scale BHK 21 suspension cell culture process.
    Pay TW; Boge A; Menard FJ; Radlett PJ
    Dev Biol Stand; 1985; 60():171-4. PubMed ID: 3899780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor.
    Rourou S; van der Ark A; Majoul S; Trabelsi K; van der Velden T; Kallel H
    Appl Microbiol Biotechnol; 2009 Nov; 85(1):53-63. PubMed ID: 19521697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an efficient veterinary rabies vaccine production process in the avian suspension cell line AGE1.CR.pIX.
    Trabelsi K; Zakour MB; Jordan I; Sandig V; Rourou S; Kallel H
    BMC Biotechnol; 2022 Jun; 22(1):17. PubMed ID: 35715843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of ERA strain of rabies virus propagated in a BHK-21 cell line.
    Lawson KF; Hertler R; Charlton KM; Campbell JB; Rhodes AJ
    Can J Vet Res; 1989 Oct; 53(4):438-44. PubMed ID: 2686831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BHK-21 cell culture rabies vaccine: immunogenicity of a candidate vaccine for humans.
    Lalosević D; Lalosević V; Lazarević-Ivanc Lj; Knezević I
    Dev Biol (Basel); 2008; 131():421-9. PubMed ID: 18634504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabies veterinary virus vaccine produced in BHK-21 cells grown on microcarriers in a bioreactor.
    Gallegos Gallegos RM; Espinosa Larios EL; Ramos Ramírez L; Kretschmer Schmid R; Aguilar Setién A
    Arch Med Res; 1995; 26(1):59-63. PubMed ID: 7711449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor.
    Trabelsi K; Rourou S; Loukil H; Majoul S; Kallel H
    J Biotechnol; 2006 Jan; 121(2):261-71. PubMed ID: 16153733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The new medium MDSS2N, free of any animal protein supports cell growth and production of various viruses.
    Merten OW; Kallel H; Manuguerra JC; Tardy-Panit M; Crainic R; Delpeyroux F; Van der Werf S; Perrin P
    Cytotechnology; 1999 Jul; 30(1-3):191-201. PubMed ID: 19003369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on pathogenic, immunogenic, and protective efficiency of fox rabies virus before and after adaptation to cell culture: application to vaccination against rabies.
    Blancou J; Aubert MF; Andral L
    Can J Microbiol; 1983 Jan; 29(1):77-83. PubMed ID: 6831313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of rabies virus produced in Vero cells grown in serum free medium.
    Trabelsi K; Ben Zakour M; Kallel H
    Vaccine; 2019 Nov; 37(47):7052-7060. PubMed ID: 31300287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.